questionsmedicales.fr
Maladies endocriniennes
Troubles gonadiques
Troubles du développement sexuel
Troubles du développement sexuel de sujets 46, XY
Syndrome de Denys-Drash
Syndrome de Denys-Drash : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Denys-Drash : Questions médicales les plus fréquentes",
"headline": "Syndrome de Denys-Drash : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Denys-Drash : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-15",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Denys-Drash"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles du développement sexuel de sujets 46, XY",
"url": "https://questionsmedicales.fr/mesh/D058490",
"about": {
"@type": "MedicalCondition",
"name": "Troubles du développement sexuel de sujets 46, XY",
"code": {
"@type": "MedicalCode",
"code": "D058490",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.391.119.096"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Denys-Drash",
"alternateName": "Denys-Drash Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D030321",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kentaro Nishi",
"url": "https://questionsmedicales.fr/author/Kentaro%20Nishi",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development."
}
},
{
"@type": "Person",
"name": "Koichi Kamei",
"url": "https://questionsmedicales.fr/author/Koichi%20Kamei",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development."
}
},
{
"@type": "Person",
"name": "Masao Ogura",
"url": "https://questionsmedicales.fr/author/Masao%20Ogura",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development."
}
},
{
"@type": "Person",
"name": "Mai Sato",
"url": "https://questionsmedicales.fr/author/Mai%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development."
}
},
{
"@type": "Person",
"name": "Kandai Nozu",
"url": "https://questionsmedicales.fr/author/Kandai%20Nozu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Kobe University Graduate School of Medicine."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35907193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2022.5.JNS22579"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the long noncoding RNA transcriptome in human preimplantation embryo development.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37770818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-023-02951-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37611624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1772705"
}
},
{
"@type": "ScholarlyArticle",
"name": "The long intergenic noncoding RNA ARES modulates root architecture in Arabidopsis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37409758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/iub.2761"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long Noncoding RNA UCA1 Correlates With Electropathology in Patients With Atrial Fibrillation.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37227342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jacep.2023.02.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles gonadiques",
"item": "https://questionsmedicales.fr/mesh/D006058"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles du développement sexuel",
"item": "https://questionsmedicales.fr/mesh/D012734"
},
{
"@type": "ListItem",
"position": 5,
"name": "Troubles du développement sexuel de sujets 46, XY",
"item": "https://questionsmedicales.fr/mesh/D058490"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syndrome de Denys-Drash",
"item": "https://questionsmedicales.fr/mesh/D030321"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Denys-Drash - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Denys-Drash",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Denys-Drash",
"description": "Comment diagnostique-t-on le syndrome de Denys-Drash ?\nQuels tests génétiques sont utilisés ?\nQuels signes cliniques indiquent ce syndrome ?\nLes échographies sont-elles utiles ?\nLe syndrome est-il héréditaire ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Denys-Drash",
"description": "Quels sont les symptômes principaux ?\nY a-t-il des signes de dysfonctionnement hormonal ?\nLes enfants sont-ils affectés dès la naissance ?\nLe syndrome affecte-t-il la croissance ?\nY a-t-il des symptômes psychologiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Denys-Drash",
"description": "Peut-on prévenir le syndrome de Denys-Drash ?\nComment le conseil génétique aide-t-il ?\nLes tests prénataux sont-ils possibles ?\nLes parents doivent-ils être testés ?\nY a-t-il des recommandations pour les familles ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Denys-Drash",
"description": "Quel est le traitement principal pour l'insuffisance rénale ?\nDes traitements hormonaux sont-ils nécessaires ?\nComment gérer les tumeurs associées ?\nY a-t-il des soins de soutien disponibles ?\nLe suivi médical est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Denys-Drash",
"description": "Quelles sont les complications possibles ?\nLe syndrome augmente-t-il le risque de cancer ?\nDes complications psychologiques peuvent-elles survenir ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Denys-Drash",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLes mutations génétiques sont-elles héréditaires ?\nY a-t-il des tests pour évaluer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030321?mesh_terms=RNA,+Long+Noncoding&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome de Denys-Drash ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'analyse génétique et l'imagerie rénale."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour identifier des mutations dans le gène WT1 sont effectués."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des malformations rénales, des anomalies génitales et des troubles de croissance."
}
},
{
"@type": "Question",
"name": "Les échographies sont-elles utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les échographies rénales aident à détecter les anomalies structurelles."
}
},
{
"@type": "Question",
"name": "Le syndrome est-il héréditaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est généralement hérité de manière autosomique dominante."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'insuffisance rénale, des anomalies génitales et des tumeurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de dysfonctionnement hormonal ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes de dysfonctionnement hormonal peuvent apparaître, affectant la puberté."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils affectés dès la naissance ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître à la naissance ou se développer durant l'enfance."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la croissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des retards de croissance peuvent être observés chez les enfants atteints."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes psychologiques peuvent survenir, liés à l'adaptation à la maladie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le syndrome de Denys-Drash ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention, mais un conseil génétique peut aider les familles à risque."
}
},
{
"@type": "Question",
"name": "Comment le conseil génétique aide-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il informe les familles sur les risques de transmission et les options disponibles."
}
},
{
"@type": "Question",
"name": "Les tests prénataux sont-ils possibles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests prénataux peuvent détecter des anomalies génétiques chez le fœtus."
}
},
{
"@type": "Question",
"name": "Les parents doivent-ils être testés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage des parents peut identifier des porteurs de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les familles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles doivent être informées des signes précoces et des soins médicaux nécessaires."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'insuffisance rénale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dialyse ou la transplantation rénale est souvent nécessaire pour l'insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Des traitements hormonaux sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements hormonaux peuvent être requis pour corriger les anomalies sexuelles."
}
},
{
"@type": "Question",
"name": "Comment gérer les tumeurs associées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tumeurs peuvent nécessiter une chirurgie, une chimiothérapie ou une radiothérapie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des soins de soutien disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien psychologique et éducatif sont souvent recommandés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour surveiller l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance rénale terminale et les cancers associés."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients ont un risque accru de développer des tumeurs, notamment rénales."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques peuvent-elles survenir ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété et la dépression sont possibles."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une approche multidisciplinaire incluant divers spécialistes."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux de syndrome et des mutations génétiques."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les garçons en raison des anomalies sexuelles."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas de preuves solides liant des facteurs environnementaux au syndrome."
}
},
{
"@type": "Question",
"name": "Les mutations génétiques sont-elles héréditaires ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les mutations dans le gène WT1 sont souvent héritées de manière autosomique dominante."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests pour évaluer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent évaluer le risque pour les membres de la famille."
}
}
]
}
]
}
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization sur...
The authors collected microsamples of the middle cerebral artery (MCA) from patients with MMD (n = 21) and patients with control conditions (n = 11) who underwent neurosurgical treatment. Using microa...
The authors detected 308 differentially expressed lncRNAs (fold change > 2, q < 0.05), including 306 upregulated and 2 downregulated lncRNAs in the MCA from patients with MMD. Regarding the prediction...
The profile of lncRNA expression in MMD lesions was different from that in the normal cerebral artery, and differentially expressed lncRNAs were identified. This study provides new insights into the p...
Infertility remains a human health burden globally. Only a fraction of embryos produced via assisted reproductive technologies (ARTs) develop to the blastocyst stage in vitro. lncRNA abundance changes...
scRNA-seq data and SUPeR-seq data were used to investigate the lncRNA profiles of human preimplantation embryos. The top 50 highly expressed unique and shared lncRNAs in each stage of preimplantation ...
The lncRNA profiles of human preimplantation embryos in the E-MTAB-3929 dataset were similar to those in the GSE71318 dataset. The ratios of overlap among the top 50 highly expressed lncRNAs between t...
Our study paves the way for understanding the regulation of developmental events, which might be beneficial for improved reproductive outcomes....
Mitochondrial dysfunction is a recognized factor in the pathogenesis of deep vein thrombosis (DVT). The role of 7S RNA, a long noncoding RNA that plays an important role in mitochondrial function, in ...
Long noncoding RNAs (lncRNAs) have emerged as important regulators of gene expression in plants. They have been linked to a wide range of molecular mechanisms, including epigenetics, miRNA activity, R...
Perpetuation of atrial fibrillation (AF) is rooted in derailment of molecular proteostasis pathways that cause electrical conduction disorders that drive AF. Emerging evidence indicates a role for lon...
In the present study, the authors explored the association between 3 cardiac lncRNAs and the degree of electropathology....
Patients had paroxysmal AF (ParAF) (n = 59), persistent AF (PerAF) (n = 56), or normal sinus rhythm without a history of AF (SR) (n = 70). The relative expression levels of urothelial carcinoma-associ...
The expression levels of SARRAH and LIPCAR were decreased in RAAs of all AF patients compared with SR. Also, in RAAs, UCA1 levels significantly correlated with the percentage of conduction block and d...
LncRNAs SARRAH and LIPCAR are reduced in RAA of AF patients, and UCA1 levels correlate with electrophysiologic conduction abnormalities. Thus, RAA UCA1 levels may aid staging of electropathology sever...
Long non coding RNAs (lncRNAs) are involved in the tumor growth, invasion, metastasis, and cancer recurrence. The improper expression of certain lncRNAs is correlated with the prognosis of the cancer ...
Renal cell carcinoma is one of the common cancers whose incidence and mortality are continuously growing worldwide. Initially, this type of tumour is usually asymptomatic. Due to the lack of reliable ...
Parkinson's disease (PD) is a neurodegenerative disease resulted from the loss of dopaminergic neurons. Here, we analyzed the role of long noncoding RNA (lncRNA) small nucleolar RNA host gene 14 (SNHG...
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were performed to determine RNA and protein expression, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-dip...
MPP...
SNHG14 promoted MPP...
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRN...
Tumor necrosis factor-α (TNF-α) and heterogenous nuclear ribonucleoprotein L (hnRNPL)-related immunoregulatory lincRNA (THRIL) is a long noncoding RNA (lncRNA) involved in various inflammatory disease...